iSpecimen introduces fresh primary viable cells for life science & cell therapy researchers

13:54 EST 25 Jan 2019 | PharmaBiz

Addressing the needs of leading life science and cell therapy researchers, iSpecimen significantly enhanced its human biospecimen offerings with the addition of fresh primary hematopoietic cells, affirming the iSpecimen

More From BioPortfolio on "iSpecimen introduces fresh primary viable cells for life science & cell therapy researchers"